EWHA WOMANS UNIVERSITY

HANKIL LEE Associate Professor

Pharmaceutical Sciences/Division of Pharmacy/Industrial Pharmaceutical Science

Pharmaceutical Science Building B #411
02-3277-4504
Research Interests
- Health Technology Assessment, Economic Evaluation, Regulatory Science, Outcomes Research, Pharmacoepidemiology

Research Record

Cost-Effectiveness of Tailored vs. Empirical Therapy for H. pylori: A Decision-Tree Analysis HELICOBACTER, 2025, v.30 no.5, e70081
SCIE Scopus dColl.
Economic Evaluation of Rituximab Versus Corticosteroid-Cyclophosphamide or Cyclosporine in Patients With Membranous Nephropathy in Republic of Korea NEPHROLOGY, 2025, v.30 no.6, e70063
SCIE Scopus dColl.
Incidence and risk of drug-induced interstitial lung disease associated with anti-neoplastic drugs Expert Opinion on Drug Safety, 2025, v.24 no.8, 899-907
SCIE Scopus dColl.
Risk of Alzheimer’s disease and Parkinson’s disease following androgen deprivation therapy in a real world nationwide cohort Scientific Reports, 2025, v.15 no.1, 23490
SCIE Scopus dColl.
Treatment Patterns and Survival Outcomes in Korean Patients With Metastatic Hormone-Sensitive Prostate Cancer in a Real-World Setting Journal of Urologic Oncology, 2025, v.23 no.3, 236-246
KCI dColl.
[학술지논문] A multicenter micro-costing analysis of flexible cystoscopic procedures in Korea INVESTIGATIVE AND CLINICAL UROLOGY, 2025, v.66 no.1 , 87-96
SCIE
[학술지논문] Analysis of Medication Adherence and Influencing Factors in Patients With Treatment-Resistant Hypertension in South Korea: A Nationwide Retrospective Cohort Study 보건의료기술평가, 2025, v.13 no.2 , 105-114
[학술지논문] Assessing the Risk of Cognitive Impairment associated with Androgen Receptor Targeting Agent Use in Metastatic Prostate Cancer: A Systematic Review of Real-world Data 약 학 회 지, 2025, v.69 no.2 , 125-134
KCI
[학술지논문] COVID-19 infection in patients with end-stage kidney disease undergoing renal replacement therapies in Korea KIDNEY RESEARCH AND CLINICAL PRACTICE, 2025, v.44 no.3 , 522-533
SCIE
[학술지논문] Clinician guidance in digital therapeutics for panic disorder: Meta-analytic dissection and implications for regulatory framing and scalable deployment JOURNAL OF ANXIETY DISORDERS, 2025, v.115 no.- , 103074-103074
SSCI
[학술지논문] Cost-Effectiveness of Tailored vs. Empirical Therapy for H. pylori: A Decision-Tree Analysis HELICOBACTER, 2025, v.30 no.5 , 70081-70081
SCIE
[학술지논문] Economic Evaluation of Rituximab Versus Corticosteroid-Cyclophosphamide or Cyclosporine in Patients With Membranous Nephropathy in Republic of Korea NEPHROLOGY, 2025, v.30 no.6 , 70063-70063
SCIE
[학술지논문] Incidence and risk of drug-induced interstitial lung disease associated with anti-neoplastic drugs EXPERT OPINION ON DRUG SAFETY, 2025, v.24 no.8 , 899-907
SCIE
[학술지논문] Insignificant difference in medication adherence to dyslipidemia drugs between visually impaired and non-disabled people in South Korea: A nationwide cohort study using claims records PLOS ONE, 2025, v.20 no.1 , 0-0
SCIE
[학술지논문] Oral Branched-Chain Amino Acids as a Cost-Effective Option for Managing Hepatic Encephalopathy YONSEI MEDICAL JOURNAL, 2025, v.66 no.11 , 713-721
SCIE
[학술지논문] Prescription trends of gastric acid suppressants and association with potential adverse events in Korea: a real-world cross-sectional study Therapeutic Advances in Gastroenterology, 2025, v.18 no.0 , 0-0
SCIE
[학술지논문] Risk of Alzheimer's disease and Parkinson's disease following androgen deprivation therapy in a real world nationwide cohort SCIENTIFIC REPORTS, 2025, v.15 no.1 , 23490-23490
SCIE
[학술지논문] Self-testing strategy to eliminate hepatitis C as per World Health Organization's goal: Analysis of disease burden and cost-effectiveness CLINICAL AND MOLECULAR HEPATOLOGY, 2025, v.31 no.1 , 166-178
SCIE
[학술지논문] Treatment Patterns and Survival Outcomes in Korean Patients With Metastatic Hormone-Sensitive Prostate Cancer in a Real-World Setting Journal of Urologic Oncology, 2025, v.23 no.3 , 236-246
KCI
[학술지논문] Regional Disparities and Related Factors in Blood Pressure and Blood Sugar Awareness in Suwon City: Analysis Using Community Health Survey Data 보건의료기술평가, 2025, v.13 no.1 , 22-30
KCI
[학술지논문] Cost-effectiveness Analysis of COMT-inhibitors as Adjuvant Treatments to Levodopa in Patients with Advanced Parkinson's Disease CLINICAL THERAPEUTICS, 2024, v.46 no.9 , 670-676
SCIE
[학술지논문] Determinants of immune checkpoint inhibitor use and factors linked to neurological adverse events in Korean lung cancer FUTURE ONCOLOGY, 2024, v.20 no.39 , 3245-3256
SCIE
[학술지논문] Expert survey on real-world data utilization and real-world evidence generation for regulatory decision-making in drug lifecycle in Korea CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, v.17 no.4 , 13801-13801
SCIE
[학술지논문] Kidney replacement therapy trends in end-stage kidney disease patients in South Korea during the COVID-19 pandemic KOREAN JOURNAL OF INTERNAL MEDICINE, 2024, v.39 no.6 , 967-978
SCIE
[학술지논문] Recent updates on treatment patterns in patients with treated attention-deficit/hyperactivity disorders from a nationwide real-world database in South Korea INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2024, v.39 no.4 , 240-249
SCIE
[학술지논문] Unveiling the chasm of economic burden from metastatic prostate cancer through a nationwide retrospective cohort study CURRENT MEDICAL RESEARCH AND OPINION, 2024, v.40 no.12 , 2155-2162
SCIE

2026-1st
- Pharmaceutical Statistics
  - Subject No 38922Class No 01
  - 1Year ( 1.5Credit , 1.5Hour) Wed 3~3 (PHM-A404)
  - Major Requisite
- Pharmacists and Society
  - Subject No 38933Class No 01
  - 2Year ( 1.5Credit , 1.5Hour) Thu 5~5 (PHM-A404)
- Pharmaco Epdemiology
  - Subject No 38985Class No 01
  - 5Year ( 1.5Credit , 1.5Hour) Wed 4~4 (POSCO261)
- Essential Pharmacy Practice Experiences
  - Subject No 39014Class No 01
  - 5Year ( 3Credit , 4.5Hour) Tue 5~10 (PHM-A214)
  - Major Requisite
- Essential Pharmacy Practice Experiences
  - Subject No 39014Class No 02
  - 5Year ( 3Credit , 4.5Hour) Mon 5~10 (PHM-A214)
  - Major Requisite
- Essential Pharmacy Practice Experiences
  - Subject No 39014Class No 03
  - 5Year ( 3Credit , 4.5Hour) Wed 5~10 (PHM-A214)
  - Major Requisite
- Essential Pharmacy Practice Experiences
  - Subject No 39014Class No 04
  - 5Year ( 3Credit , 4.5Hour) Mon 5~10 (PHM-A214)
  - Major Requisite
- Pharmaceutical Statistics
  - Subject No 39026Class No 01
  - 1Year ( 1.5Credit , 1.5Hour) Wed 5~5 (POSCO462)
  - Major Requisite
- Pharmacists and Society
  - Subject No 39038Class No 01
  - 2Year ( 1.5Credit , 1.5Hour) Thu 5~5 (PHM-A404)
- Pharmaco Epdemiology
  - Subject No 39090Class No 01
  - 5Year ( 1.5Credit , 1.5Hour) Wed 2~2 (POSCO551)
  - Major Requisite
- Project Analysis Ⅰ
  - Subject No G16659Class No 01
  - Year ( 3Credit , 3Hour) Fri 7~8 (PHM-)
- Principles of Pharmaceutical Economics and Policy
  - Subject No G17175Class No 01
  - Year ( 3Credit , 3Hour) Wed 6~7 (PHM-)
- Methods in Economic Evaluation in Pharmaceuticals Ⅱ
  - Subject No G17177Class No 01
  - Year ( 3Credit , 3Hour) Wed 8~9 (PHM-)
- Advanced Biotechnology Equipment and Experiments
  - Subject No G18929Class No 01
  - Year ( 3Credit , 3Hour) Tue 6~7 (PHM-)
- Principles of Pharmaceutical Economics and Policy
  - Subject No G18955Class No 01
  - Year ( 3Credit , 3Hour) Wed 6~7 (PHM-)
- Social Pharmacy
  - Subject No AP530Class No 01
  - Year ( 3Credit , 3Hour)
- Social Pharmacy
  - Subject No AR530Class No 01
  - Year ( 3Credit , 3Hour)
2025-2nd
- Honors research
  - Subject No 37803Class No 01
  - 4Year ( 1Credit , 1Hour)
- Honors Research Ⅰ
  - Subject No 38982Class No 01
  - 4Year ( 1.5Credit
- Pharmacy Administration 강의 계획서 상세보기
  - Subject No 38990Class No 01
  - 4Year ( 1.5Credit , 1.5Hour) Fri 3~3 (PHM-A404)
  - Major Requisite,Language Changed
- Honors Research Ⅰ
  - Subject No 39087Class No 01
  - 4Year ( 1.5Credit
- Pharmacy Administration 강의 계획서 상세보기
  - Subject No 39095Class No 01
  - 4Year ( 1.5Credit , 1.5Hour) Fri 4~4 (PHM-A404)
  - Major Requisite,Language Changed
- Strategic Management & Healthcare 강의 계획서 상세보기
  - Subject No 39249Class No 01
  - 4Year ( 3Credit , 3Hour) Tue 5~5 (PHM-A104) , Tue 6~6 (PHM-A104)
  - Major Requisite,Language Changed
- Methods in Economic Evaluation in Pharmaceuticals Ⅰ 강의 계획서 상세보기
  - Subject No G16816Class No 01
  - Year ( 3Credit , 3Hour) Wed 8~9 (PHM-)
- Methods in Economic Evaluation 강의 계획서 상세보기
  - Subject No G18086Class No 01
  - Year ( 3Credit , 3Hour) Wed 8~9 (PHM-)
2025-1st
- Pharmaceutical Statistics 강의 계획서 상세보기
  - Subject No 38922Class No 01
  - 1Year ( 1.5Credit , 1.5Hour) Wed 3~3 (PHM-A404)
  - Major Requisite,Language Changed
- Pharmacists and Society 강의 계획서 상세보기
  - Subject No 38933Class No 01
  - 2Year ( 1.5Credit , 1.5Hour) Tue 4~4 (HAK251)
- Pharmaceutical Statistics
  - Subject No 39026Class No 01
  - 1Year ( 1.5Credit , 1.5Hour) Wed 5~5 (POSCO462)
  - Major Requisite,Language Changed
- Pharmaceutical Statistics Computer Lab
  - Subject No 39027Class No 01
  - 1Year ( 1.5Credit , 1.5Hour) Wed 6~6 (POSCO159)
  - Major Requisite,Language Changed
- Pharmacists and Society 강의 계획서 상세보기
  - Subject No 39038Class No 01
  - 2Year ( 1.5Credit , 1.5Hour) Tue 4~4 (HAK251)
- Introduction to Pharmaceutical Research
  - Subject No 39045Class No 01
  - 2Year ( 1.5Credit , 1.5Hour) Thu 6~6 (PHM-A104)
- Pharmacoepidemiology 강의 계획서 상세보기
  - Subject No G17173Class No 01
  - Year ( 3Credit , 3Hour) Fri 8~9 (PHM-)
  - Professor Determined
- PharmacoEpidemiology 강의 계획서 상세보기
  - Subject No G18085Class No 01
  - Year ( 3Credit , 3Hour) Fri 8~9 (PHM-)
  - Professor Determined

Academic Background

YONSEI UNIVERSITY 약학박사(약학과)

Ewha Womans University 약학석사(생명약학부)

Ewha Womans University 약학사(제약학과)

Work Experience

아주대 2021-03-01 ~ 2025-02-28

HANKIL LEE Associate Professor

Research Record

Courses

Academic Background

Work Experience